|
|
Parathyroid-Specific Deletion of Klotho Unravels a Novel Calcineurin-Dependent FGF23 Signaling Pathway That Regulates PTH Secretion
|
|
|
|
|
نویسنده
|
olauson h. ,lindberg k. ,amin r. ,sato t. ,jia t. ,goetz r. ,mohammadi m. ,andersson g. ,lanske b. ,larsson t.e.
|
منبع
|
plos genetics - 2013 - دوره : 9 - شماره : 12
|
چکیده
|
Klotho acts as a co-receptor for and dictates tissue specificity of circulating fgf23. fgf23 inhibits pth secretion,and reduced klotho abundance is considered a pathogenic factor in renal secondary hyperparathyroidism. to dissect the role of parathyroid gland resident klotho in health and disease,we generated mice with a parathyroid-specific klotho deletion (pth-kl-/-). pth-kl-/- mice had a normal gross phenotype and survival; normal serum pth and calcium; unaltered expression of the pth gene in parathyroid tissue; and preserved pth response and sensitivity to acute changes in serum calcium. their pth response to intravenous fgf23 delivery or renal failure did not differ compared to their wild-type littermates despite disrupted fgf23-induced activation of the mapk/erk pathway. importantly,calcineurin-nfat signaling,defined by increased mcip1 level and nuclear localization of nfatc2,was constitutively activated in pth-kl-/- mice. treatment with the calcineurin-inhibitor cyclosporine a abolished fgf23-mediated pth suppression in pth-kl-/- mice whereas wild-type mice remained responsive. similar results were observed in thyro-parathyroid explants ex vivo. collectively,we present genetic and functional evidence for a novel,klotho-independent,calcineurin-mediated fgf23 signaling pathway in parathyroid glands that mediates suppression of pth. the presence of klotho-independent fgf23 effects in a klotho-expressing target organ represents a paradigm shift in the conceptualization of fgf23 endocrine action. © 2013 olauson et al.
|
|
|
آدرس
|
division of renal medicine,department of clinical science,intervention and technology,karolinska institutet,stockholm, Sweden, division of renal medicine,department of clinical science,intervention and technology,karolinska institutet,stockholm, Sweden, division of renal medicine,department of clinical science,intervention and technology,karolinska institutet,stockholm, Sweden, department of oral medicine,infection,and immunity,harvard school of dental medicine,boston,ma, United States, division of renal medicine,department of clinical science,intervention and technology,karolinska institutet,stockholm, Sweden, department of biochemistry and molecular pharmacology,new york university school of medicine,new york,ny, United States, department of biochemistry and molecular pharmacology,new york university school of medicine,new york,ny, United States, division of pathology,department of laboratory medicine,karolinska institutet and karolinska university hospital huddinge,stockholm, Sweden, department of oral medicine,infection,and immunity,harvard school of dental medicine,boston,ma, United States, division of renal medicine,department of clinical science,intervention and technology,karolinska institutet,stockholm,sweden,department of nephrology,karolinska university hospital,stockholm, Sweden
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|